meddevicedb.com FDA Device Reference

NaturaLyte Dry Bicarbonate Concentrate (Rx-10 Bag), NaturaLyte Dry Bicarbonate Concentrate (Rx-12 Bag), NaturaLyte Dry Bicarbonate Concentrate (Carton)

K191474 Class II Traditional
Decision Date
2020-02-24
Sponsor / Applicant
Fresenius Medical Care Renal Therapies Group, LLC

Technical Specification

510(k) Submission ID K191474
Product Code KPO
Medical Specialty / Panel Gastroenterology, Urology
Regulation Citation 21 CFR 876.5820
Decision Date 2020-02-24
Clearance Pathway Traditional

Official Documentation

FDA CDRH Summary / statement of record

View FDA Summary PDF

Clearance Summary

NaturaLyte Dry Bicarbonate Concentrate (Rx-10 Bag), NaturaLyte Dry Bicarbonate Concentrate (Rx-12 Bag), NaturaLyte Dry Bicarbonate Concentrate (Carton) received FDA 510(k) clearance under submission number K191474, sponsored by Fresenius Medical Care Renal Therapies Group, LLC. The device was reviewed via the Traditional premarket notification pathway and assigned to the Gastroenterology, Urology review panel. The statutory decision date of record is 2020-02-24.

Classification & Regulation

This clearance is catalogued under FDA product code KPO and 21 CFR 876.5820, within the Gastroenterology, Urology review panel as a Class II device.